Download PDF. 1 / 3 Pages. Previous article. Go back to website. Next article. HARRIS D., Paul BRINCK M., Patricio. Un análisis retrospectivo de cavernomatosis de la vena porta en Chile: II. Hemorragia, tratamiento y pronóstico. Rev. chil. HARRIS D., Paul BRINCK M., Patricio. Un análisis retrospectivo de cavernomatosis de la vena porta en Chile.: I. Perfil clínico y de laboratorio. Rev. chil. pediatr.

Author: Doubei Kirr
Country: Nicaragua
Language: English (Spanish)
Genre: Environment
Published (Last): 26 November 2012
Pages: 71
PDF File Size: 14.17 Mb
ePub File Size: 11.4 Mb
ISBN: 721-6-21929-232-6
Downloads: 93449
Price: Free* [*Free Regsitration Required]
Uploader: Meztirn

Iatrogenic fine needle aspiration of abdominal masses etc. Eur J Gastroenterol Hepatol. This vascular neo-formation begins in a few days after portal vein obstruction, and finalizes within 3 to 5 wk[ 67 ].

There was a problem providing the content you requested

Furthermore, contrast-enhanced MR angiography is useful to assess flow direction in the portal venous system and its patency, to identify a cavernomatous transformation, to determine the presence of varices, and to verify the correct function of surgical shunts[ 8182 ].

Furthermore, hypersplenism and, consequently, pancytopenia, are commonly present in chronic PVT[ 1 ]; however, if one branch of the portal vein is preserved and the portal caveronma is quite normal, they may even be absent.

Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Moreover, advanced age, malignancy, cirrhosis, mesenteric vein thrombosis, absence of abdominal inflammation, and serum levels of aminotransferase and albumin are associated with reduced survival[ 65 ].

Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Protean manifestations of pylethrombosis.

Malformación cavernomatosa de la vena porta

Venaa of paraumbilical vein CT scan ; E: Finally, shunt surgery distal splenorenal shunt or Rex shunt, in children might be applied as the last choice, and only in absence of splenic or superior mesenteric vein thrombosis[ ]. Bayraktar Y, Harmanci O. Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Original cause As first, local causes such as cirrhosis, primary or metastatic malignancies, porya, liver cysts, vascular abnormalities webs or aneurysmsand pancreatitis have to be excluded.


If CT scan is not rapidly available, obtain Doppler-sonography Obtain Doppler-sonography, then either CT scan or MRI, before and after a vascular contrast agent, to make a diagnosis of chronic PVT In patients with acute PVT and high fever, septic pylephlebitis should be considered, whether or not an abdominal source of infection has been identified, and blood cultures should be routinely obtained Base the diagnosis ;orta the absence of a visible normal portal vein and its ven with serpiginous veins In acute PVT, the possibility of intestinal infarction should be considered from presentation until resolution of pain.

Transjugular intrahepatic caveenoma shunt. At this stage, the development of a hyperkinetic circulation, characterized by low systemic vascular resistance and a high cardiac output, is common[ 3 ].

A lz mutation of JAK2 in myeloproliferative disorders. Although in the general population PVT is considered a rare event, its prevalence among cirrhotic patients ranges between 4.

Base the diagnosis on the absence of a visible normal portal vein and its replacement with serpiginous veins. Anticoagulation in cirrhotic patients The ubiquitous and long-term use of anticoagulants in cirrhotic patients with PVT should not be considered correct practice, until their safety and efficacy has been completely tested[ 62 ].

Moreover, PVT might have indirect effects on other abdominal organs, causing intestinal ischemia and infarction, or predisposition to vascular neoformation and gastrointestinal bleeding. Although PVT might be compared to other cases of deep vein thrombosis, there is no randomized controlled trial regarding the use of anticoagulants in acute PVT[ ]. It appears to be more accurate than US or computed tomography CT scans in discovering portal invasion by tumors[ 7778 ].

However, signs of intestinal ischemia or infarction, or an underlying prothrombotic disorder should be considered an indication for anticoagulants in cirrhotic patients, although only after an adequate prophylaxis for variceal bleeding[ 2]. Vascular disorders of vvena liver. If CT scan is not rapidly available, obtain Doppler-sonography.

Related Posts (10)  LATIHAN KEGEL PDF

Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment

Acute thrombosis of the splanchnic veins. In acute PVT, the possibility of intestinal infarction should be considered from presentation until resolution of pain.

Current state of portosystemic shunt surgery. Nonmalignant portal vein thrombosis in adults. However, the relatively low prevalence of genetic, in respect to acquired, thrombophilic disorders, might represent a potential diagnostic matter in PVT patients, and should be considered carefully in clinical practice[ 30 ].

Transhepatic thrombolysis in acute portal vein thrombosis after laparoscopic splenectomy. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous caverboma.

However, efficacy is significantly lower and mortality increased in patients who undergo thrombolysis, if compared to conservative treatment[ 59, ].

In PVT patients, liver function is typically conserved. Several causes can be involved in the pathogenesis of PVT and, frequently, ee than one coexist. If no local risk factor is found, the presence of a thrombophilic disorder must be investigated. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Current outcome of portal vein thrombosis in adults: Portal cvernoma thrombosis in adults: Transjugular intrahepatic portosystemic shunt TIPS in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients.

Other modalities of treatment should be adopted only in case of partial or absent PVT resolution[ 12]. Other treatments Thrombolytic therapy, given either into the systemic venous circulation, the superior mesenteric artery, or the portal vein via a transjugular or transhepatic route, is also effective to provide recanalization in acute PVT[ – ].